The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite a growing number of biosimilar approvals, market uptake remains a challenge.

Moving Biosimilars Forward in a Hesitant Market

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Automating the Future of Fill/Finish

Topic

Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, 

. He previously spent nearly a decade as a news anchor, reporter, and producer at New Jersey 101.5 FM.

Articles

SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product.

AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart Failure Gene Therapy

Feliza Mirasol is the science editor for 

Evonik's plant-based squalene, PhytoSquene, used in parenteral drug delivery applications, won the CPHI Excellence in Pharma Award in the “Sustainability” category. 

CPHI Award Granted to Evonik for Plant-based Adjuvant Used in Parenteral Drug Delivery

Aseptic fill/finish of biopharmaceuticals requires an understanding of the structure and limitations of each molecule.

Understanding Molecule Sensitivity in Aseptic Fill/Finish

Dayna Turner is group leader, Science & Technology, at STERIS, Saint Louis, Mo.

Dijana Hadziselimovic is laboratory manager, Technical Services, at STERIS, Saint Louis, Mo.

Paul Lopolito is a technical services specialist at STERIS, Mentor, OH.

Mary Schanne is senior account manager at STERIS, Saint Louis, Mo.

Amy Thanavaro is manager, Science & Technology, at STERIS, Saint Louis, Mo.

Jeff Felker is deputy director, Cleaning Validation SME, Sanofi MSAT Swiftwater, Pa.

In this article, the authors explored the elimination of a water rinse and blow down following the caustic wash step, examining potential safety considerations, the effect on the quality of the cleaning process, and the potential benefit of implementing this change.

Strategic Changes to a Legacy Cleaning Approach Result in a More Sustainable Process

Videos

At CPHI Milan, Nicolas Camper, senior director—Bioconjugation Chemistry, Abzena, spoke about new developments in ADC technologies, including the role of complex chemistries.

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Solving the challenge of better-stabilized temperature-sensitive biomolecules hinges on innovative formulation strategies.

Prioritizing Formulation Strategies for Temperature-Sensitive Biotherapeutics

Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Thermo Fisher Introduces New CDMO and CRO Services at CPHI Milan 2024

At this year's CPHI Milan, Camille Dumont, PhD, manager, customer applications, Lonza, discussed current industry trends that are impacting oral solid dose formulation work.

A Discussion on Industry Trends and Their Influence on Oral Solid Dose Formulations (CPHI Milan 2024)

Chris Spivey is the editorial director of 

In episode 1, cell and gene therapy experts Dr. Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT. 

Buy, Sell, Hold: Cell and Gene Therapy

Editor of Pharmaceutical Technology Europe

At CPHI Milan, Zaim Gashi, area sales manager of Steriline, discussed the evolution of aseptic processing equipment to stay compliant with current regulations.